Vaccination series: 3 doses administered orally to infants, w/ the 1st dose administered at 6-12 wk of age & the subsequent doses at min of 4-wk intervals.
Not for administration via inj. Immunocompromised patients eg, individuals w/ malignancies or who are otherwise immunocompromised, or those receiving immunosuppressive therapy; HIV infection; recipient of blood transfusion or blood products including Ig w/in 42 days; infants w/ active GI illness, chronic diarrhea or growth retardation or history of congenital abdominal disorders or intussusception; acute infection or febrile illness. Infant <6 wk.
Sign Out
874aad7a-c78e-4333-8303-af0700e28223.GIF)
